2010 annual financial data
Regeneron Pharmaceuticals 2010 Operating margin
Regeneron Pharmaceuticals 2010 operating margin with verified reported values.
Direct answer
Operating margin was -21.23%.
Operating income was -97,472,000 USD and net income was -104,468,000 USD.
Operating cash flow was 96,344,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 459,074,000 USD
- Operating income
- -97,472,000 USD
- Net income
- -104,468,000 USD
- Operating cash flow
- 96,344,000 USD